Connie L. Erickson‐Miller

Phase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist

J.M. Jenkins, Daphne Williams, Yanli Deng et al. · Blood · 2007 · 297 citations

Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia

Pinelopi P. Kapitsinou, Qingdu Liu, Travis L. Unger et al. · Blood · 2010 · 295 citations · Full text

Preclinical Activity of Eltrombopag (SB-497115), an Oral, Nonpeptide Thrombopoietin Receptor Agonist

Connie L. Erickson‐Miller, Evelyne Delorme, Shin‐Shay Tian et al. · Stem Cells · 2008 · 280 citations · Full text

Platelet Numbers, Immunology, Blood Cell +21

Discovery and characterization of a selective, nonpeptidyl thrombopoietin receptor agonist

Connie L. Erickson‐Miller, Evelyne Delorme, Shin‐Shay Tian et al. · Experimental Hematology · 2005 · 202 citations · Full text

Thrombopoiesis, Thrombosis, Signal Transduction +9

Endothelial HIF-2 mediates protection and recovery from ischemic kidney injury

Pinelopi P. Kapitsinou, Hideto Sano, Mark Michael et al. · Journal of Clinical Investigation · 2014 · 180 citations · Full text

Acute Lung Injury, Ischemia Reperfusion, Renal Pathology +26